Mei‐Hui Hsu
- Molecular Biology top 10%
- Pharmacology top 0.5%
- Biochemistry top 1%
- Oncology top 10%
- Physiology top 10%
- Co-authors
- Eric F. JohnsonKeith J. GriffinÜzen SavasC.D. StoutA. Scott MuerhoffL. Ashley CowartJohn R. FalckJorge H. Capdevila
- Topics
- Pharmacogenetics and Drug Metabolism (14 papers)Drug Transport and Resistance Mechanisms (9 papers)Peroxisome Proliferator-Activated Receptors (9 papers)
- Partner nations
- United StatesTaiwanUnited Kingdom
In The Last Decade
Mei‐Hui Hsu
32 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 1.0k
- Pharmacology 679
- Biochemistry 435
- Oncology 349
- Physiology 254
Countries citing papers authored by Mei‐Hui Hsu
This map shows the geographic impact of Mei‐Hui Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Hui Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Hui Hsu more than expected).
Fields of papers citing papers by Mei‐Hui Hsu
This network shows the impact of papers produced by Mei‐Hui Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Hui Hsu. The network helps show where Mei‐Hui Hsu may publish in the future.
Co-authorship network of co-authors of Mei‐Hui Hsu
This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Hui Hsu. A scholar is included among the top collaborators of Mei‐Hui Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Hui Hsu. Mei‐Hui Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 34 | |
| 6 | 19 | |
| 7 | 36 | |
| 8 | 25 | |
| 9 | 39 | |
| 10 | 23 | |
| 11 | 111 | |
| 12 | 37 | |
| 13 | 43 | |
| 14 | 66 | |
| 15 | 39 | |
| 16 | 161 | |
| 17 | 59 | |
| 18 | 7 | |
| 19 | 32 | |
| 20 | 40 |
About Mei‐Hui Hsu
Mei‐Hui Hsu is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). The work is most often cited by research in Pharmacology (679 citations), Biochemistry (435 citations) and Molecular Biology (1.0k citations). Mei‐Hui Hsu has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include Eric F. Johnson, Keith J. Griffin, Üzen Savas, C.D. Stout, A. Scott Muerhoff, L. Ashley Cowart, John R. Falck, Jorge H. Capdevila, Shouzuo Wei and Wan‐Ping Hu. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.